Neutrophil Gelatinase-Associated Lipocalin, Fibroblast Growth Factor 23, and Soluble Klotho in Long-Term Kidney Donors

BACKGROUND: The best treatment for end-stage renal disease (ESRD) is kidney transplantation. Twenty-seven percent of transplantations in Norway are from living donors. Recent studies have shown an increased risk of ESRD and increased mortality in donors. The aim of this study was to determine if the...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorsen, Inga Strand, Bleskestad, Inger Hjørdis, Jonsson, Grete, Skadberg, Øyvind, Gøransson, Lasse Gunnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122995/
https://www.ncbi.nlm.nih.gov/pubmed/27920796
http://dx.doi.org/10.1159/000450621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122995/
https://www.ncbi.nlm.nih.gov/pubmed/27920796
http://dx.doi.org/10.1159/000450621

Ejemplares similares